A 80 year old lady body weight 30 kg platelets 40k
Ischemic stroke
Reading File
Finding Sources
Finding Sources
Searching PubMed
ischemic stroke thrombolysis thrombocytopenia low platelet count
Reading File
Reading File
Finding Sources
Reading File
Finding Sources
I now have all the critical textbook data. Let me compile a comprehensive clinical answer.
Acute Ischemic Stroke — 80-year-old, 30 kg, Platelets 40,000/µL
This patient has three major clinical concerns that each modify standard stroke management:
1. IV Thrombolysis (Alteplase/rtPA) — CONTRAINDICATED
The platelet threshold is the decisive factor
"In patients without history of thrombocytopenia, treatment with IV rtPA can be initiated before availability of platelet count but should be discontinued if platelet count is <100,000/µL." — Goldman-Cecil Medicine, Table 376-7
A platelet count of 40,000/µL is an absolute contraindication to IV thrombolysis. This is listed explicitly in both the FDA label and AHA/ASA guidelines because:
- Platelets <100,000 dramatically increases the risk of symptomatic intracranial hemorrhage (sICH)
- The hemostatic plug required to contain any hemorrhagic transformation cannot form
Even if platelets were borderline, this patient has additional factors making thrombolysis extremely high-risk:
- Age >80 (relative contraindication for 3–4.5 h window per AHA 2019)
- Low body weight (30 kg) — increases hemorrhagic risk at standard dosing
2. Alteplase Dose (IF somehow considered — for reference only)
Standard dose: 0.9 mg/kg IV, maximum 90 mg (10% as bolus over 1 min, remainder over 60 min)
For 30 kg: 27 mg total (2.7 mg bolus + 24.3 mg infusion)
This calculation is moot here — thrombocytopenia at 40k is an absolute contraindication. Dose is listed only for academic reference.
(Rosen's Emergency Medicine, Table 87.5; Katzung, Chapter on thrombolytics)
3. Mechanical Thrombectomy — Consider Urgently
With IV thrombolysis contraindicated, endovascular thrombectomy (EVT) becomes the priority if the patient has:
- Large vessel occlusion (LVO) on CTA/MRA
- Favorable penumbra on perfusion imaging
- NIHSS ≥6, premorbid mRS 0–1
- Within 6–24 hours of onset (depending on imaging criteria)
Platelets of 40,000 are a relative concern (risk of puncture site hematoma, intracranial hemorrhage) but EVT is not absolutely contraindicated at this level. Neurovascular surgery/interventional radiology must weigh procedural risk.
4. Antiplatelet Therapy
- Aspirin 160–325 mg should be started within 24–48 hours if not thrombolysed
- At platelets of 40,000, aspirin further inhibits platelet function — use with caution and reassess platelet trend
- Dual antiplatelet therapy (aspirin + clopidogrel) for minor stroke/TIA is generally avoided at this platelet count given excessive bleeding risk
- Consider the cause of thrombocytopenia before antiplatelet use (ITP, TTP, heparin-induced — each has different implications)
5. Anticoagulation
- Urgent anticoagulation is NOT recommended for acute ischemic stroke regardless of etiology (Goldman-Cecil)
- With platelets 40,000, the bleeding risk of heparin/LMWH is prohibitively high — avoid unless there is a separate compelling indication (e.g., DVT, mechanical valve)
6. Investigate the Thrombocytopenia
The cause of low platelets is critical and may change management:
| Cause | Implication for Stroke |
|---|---|
| ITP | Autoimmune; may respond to IVIG/steroids → could raise platelets for intervention |
| TTP | ADAMTS13 deficiency; stroke is part of TTP — treat with plasmapheresis |
| Heparin-induced (HIT) | Thrombotic; avoid heparin; use argatroban/fondaparinux |
| Bone marrow failure / malignancy | Poor prognosis; platelet transfusion may be needed before intervention |
| DIC | Treat underlying cause; FFP + platelets |
TTP must be excluded — it is a medical emergency presenting with MAHA + thrombocytopenia + neurological symptoms.
7. Supportive Stroke Care (Always Applicable)
- Admit to stroke unit (improves outcomes regardless of thrombolysis)
- BP management: Do NOT lower BP aggressively if not thrombolysed — target <220/120 in first 24h
- Blood glucose: Keep 140–180 mg/dL
- Antipyretics if febrile
- DVT prophylaxis: Compression stockings (avoid LMWH at this platelet count)
- Swallowing assessment before oral intake
- Early mobilisation and rehabilitation
Summary Table
| Decision | Recommendation | Rationale |
|---|---|---|
| IV Alteplase | Absolute contraindication | Platelets <100,000/µL |
| Mechanical Thrombectomy | Evaluate urgently (CTA/MRI) | Best option for LVO |
| Aspirin | Start 160–325 mg after 24h (cautious) | Platelet count borderline low |
| Dual antiplatelet | Avoid | Excess bleeding risk |
| Anticoagulation | Avoid acutely | Not indicated; high bleed risk |
| Platelet transfusion | Consider if EVT planned | Target >80–100k for intervention |
| Investigate thrombocytopenia | Urgent — TTP? HIT? ITP? | Changes entire management |
Key reference: Rosen's Emergency Medicine (2023), Table 87.5; Goldman-Cecil Medicine, Tables 376-7 and 376-8; Tintinalli's Emergency Medicine, Stroke chapter.
⚠️ Clinical note: Always involve neurology/stroke team, hematology, and interventional neuroradiology in shared decision-making for this high-complexity patient.
This is a shared conversation. Sign in to Orris to start your own chat.